Ropeginterferon alfa-2b Recruiting Phase 2 Trials for Chronic Myeloid Leukemia in Remission Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03117816ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission